Relationship between neck circumference,insulin resistance and arterial stiffness in overweight and obese subjects

Abstract

Background

Only a few studies have investigated the relationship between neck circumference and cardiometabolic risk. The aim of this study was to assess the relationships between neck circumference, waist circumference, metabolic variables and arterial stiffness in a group of overweight and obese subjects evaluating a possible independent role of neck circumference in determining arterial stiffness.

Methods and results

We studied 95 subjects (53 women) with an age range of 20–77 years and body mass index range from 25.69 to 47.04 kg/m². In each subject we evaluated body mass index, waist, hip and neck circumference, systolic and diastolic blood pressure, insulin, fasting glucose, cholesterol, low-density lipoprotein and high-density lipoprotein cholesterol and triglycerides. Arterial stiffness was assessed by carotid-femoral pulse wave velocity (PWVcf) and carotid-radial pulse wave velocity (PWVcr). Both PWVcf and PWVcr were higher in subjects with high values of neck circumference compared with subjects with normal values of neck circumference. Subjects with high values of neck circumference and abdominal obesity presented higher values of mean arterial pressure, PWVcr and homeostasis model assessment (HOMA) index and lower values of high-density lipoprotein than subjects with only abdominal obesity. Two models of stepwise multiple regression were performed in order to evaluate the combined effect of independent variables on arterial stiffness. In the first model PWVcf was considered a dependent variable, and age, gender, systolic blood pressure, triglycerides, high-density lipoprotein cholesterol, waist circumference, neck circumference, HOMA index and the use of anti-hypertensive medications were considered independent variables. Age, systolic blood pressure, triglycerides and waist circumference were significant predictors of PWVcf, explaining 65% of its variance. In the second model, in which PWVcr was considered a dependent variable, neck circumference and gender were significant predictors of PWVcr, explaining 24% of its variance.

Conclusions

These findings emphasise the need to measure not only waist but even neck circumference to better stratify and identify individuals at increased cardiometabolic risk, as upper-body subcutaneous fat is a novel, easily measured fat depot.

Keywords

Neck circumference pulse wave velocity high-density lipoprotein cholesterol HOMA index obesity

Get full access to this article

View all access options for this article.

References

Fantin

Di Francesco

Rossi

et al.

Abdominal obesity and subclinical vascular damage in the elderly. J Hypertens 2010; 28: 333–339.

National Obesity Education Initiative of the National Heart, Lung, and Blood Institute (NHLBI). Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report, Bethesda, MD: National Institutes of Health, 1998.

Bosello

Zamboni

. Visceral obesity and metabolic syndrome. Obesity Rev 2000; 1: 47–56.

Fitch

Stanley

Looby

et al.

Relationship between neck circumference and cardiometabolic parameters in HIV-infected and non-HIV-infected adults. Diabetes Care 2011; 34: 1026–1031.

Preis

Massaro

Hoffmann

et al.

Neck circumference as a novel measure of cardiometabolic risk: The Framingham Heart Study. J Clin Endocrinol Metab 2010; 95: 3701–3710.

Preis

Pencina

D’Agostino

Sr et al.

Neck circumference and the development of cardiovascular disease risk factors in the Framingham Heart Study. Diabetes Care 2013; 36: e3–e3.

Liang

Teng

et al.

Neck circumference and insulin resistance in Chinese adults: The Cardiometabolic Risk in Chinese (CRC) Study. Diabetes Care 2013; 36: e145–e146.

Ben-Noun

Laor

. Relationship of neck circumference to cardiovascular risk factors. Obes Res 2003; 11: 226–231.

Ben-Noun

Laor

. Relationship between changes in neck circumference and cardiovascular risk factors. Exp Clin Cardiol 2006; 11: 14–20.

10.

Onat

Hergenç

Yüksel

et al.

Neck circumference as a measure of central obesity: Associations with metabolic syndrome and obstructive sleep apnea syndrome beyond waist circumference. Clin Nutr 2009; 28: 46–51.

11.

Zhou

Zhu

et al.

Neck circumference as an independent predictive contributor to cardio-metabolic syndrome. Cardiovasc Diabetol 2013; 12: 76–76.

12.

Yang

Yuan

et al.

Beijing Community Diabetes Study Group. Neck circumference positively related with central obesity, overweight, and metabolic syndrome in Chinese subjects with type 2 diabetes: Beijing Community Diabetes Study. Diabetes Care 2010; 33: 2465–2467.

13.

Vallianou

Evangelopoulos

Bountziouka

et al.

Neck circumference is correlated with triglycerides and inversely related with HDL cholesterol beyond BMI and waist circumference. Diabetes Metab Res Rev 2013; 29: 90–97.

14.

Rosenquist

Massaro

Pencina

et al.

Neck circumference, carotid wall intima-media thickness, and incident stroke. Diabetes Care 2013; 36: e153–e154.

15.

American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Obstructive Sleep Apnea. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: An updated report by the American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Obstructive Sleep Apnea. Anesthesiology 2014; 120: 268–286.

16.

Pedrosa

Drager

Gonzaga

et al.

Obstructive sleep apnea: The most common secondary cause of hypertension associated with resistant hypertension. Hypertension 2011; 58: 811–817.

17.

ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens 2013; 31: 1925–1938.

18.

Ben-Noun

Sohar

Laor

. Neck circumference as a simple screening measure for identifying overweight and obese patients. Obes Res 2001; 9: 470–477.

19.

Laurent

Kingwell

Bank

et al.

Clinical applications of arterial stiffness: Therapeutics and pharmacology. Am J Hypertens 2002; 15: 453–458.

20.

Block

Jarret

Jr Levine

Use of a single color reagent to improve the automated determination of serum total cholesterol. In: Skeggs

LT Jr

(ed). Automation in analytical chemistry, New York: Mediad, 1974, pp. 345–353.

21.

Kessler

Lederer

Fluorimetric measurement of triglycerides. In: Skeggs

Jr (ed). Automation in analytical chemistry, New York: Mediad, 1965, pp. 341–350.

22.

Friedewald

Levy

Fredrickson

. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.

23.

Bonora

Targher

Alberiche

et al.

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57–63.

24.

Fantin

Rossi

Cazzadori

et al.

Central and peripheral fat and subclinical vascular damage in older women. Age Ageing 2013; 42: 359–365.

25.

Sutton-Tyrrell

Newmann

Simonsick

et al.

Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging and body composition. Hypertension 2001; 38: 429–433.

26.

Nordstrand

Gjevestad

Dinh

et al.

The relationship between various measures of obesity and arterial stiffness in morbility obese patients. BMC Cardiovasc Disord 2011; 11: 7–7.

27.

Wannamethee

Shaper

Durrington

et al.

Hypertension, serum insulin, obesity and the metabolic syndrome. J Hum Hypertens 1998; 12: 735–741.

28.

Fantuzzi

Mazzone

. Adipose tissue and atherosclerosis: Exploring the connection. Arterioscler Thromb Vasc Biol 2007; 27: 996–1003.

29.

Kofler

Nickel

Weis

. Role of cytokines in cardiovascular diseases: A focus on endothelial responses to inflammation. Clin Sci (Lond) 2005; 108: 205–213.

30.

Oda

Taniguchi

Yokoyama

. Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci 2001; 47: 141–150.

31.

Nielsen

Guo

Johnson

et al.

Splanchnic lipolysis in human obesity. J Clin Invest 2004; 113: 1582–1588.

32.

Santosa

Jensen

. Why are we shaped differently, and why does it matter? Am J Physiol Endocrinol Metab 2008; 295: E531–E535.

33.

de Almeida-Pititto

Ribeiro-Filho

Santos

et al.

Association between carotid intima-media thickness and adiponectin in participants without diabetes or cardiovascular disease of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Eur J Prev Cardiol 2017; 24: 116–122.

34.

Asmar

. Effect of antihypertensive agents on arterial stiffness as evaluated by pulse wave velocity: Clinical implications. Am J Cardiovasc Drugs 2001; 1: 387–397.

35.

Lunder

Janic

Sabovic

. Reduction of age-associated arterial wall changes by low-dose valsartan. Eur J Prev Cardiol 2012; 19: 1243–1249.